Patritumab Biosimilar - Research Grade

Human

HER3

5mg/ml

Human IgG1 Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects HER3

Blue ice

Human epidermal growth factor receptor 3 (HER3/ERBB3) is a signalling co-receptor that drives resistance in many carcinomas, a recurring target in oncology research. This recombinant anti-human HER3 monoclonal is an unconjugated, non-therapeutic analog of patritumab, supplied for research use only (RUO). Manufactured to in vivo standards with low endotoxin, it is offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Applications include functional assays, receptor-blockade and signalling studies, reproducible controls, and in vivo tumour models, providing the lot-to-lot consistency expected by heavy-usage oncology research programmes.

U3-1287;ERBB3,receptor tyrosine-protein kinase erbB-3, HER3

P21860

ICH3002

https://www.imgt.org/mAb-DB/